Loading…

Host Cell Factor Requirement for Hepatitis C Virus Enzyme Maturation

The cellular chaperone, HSP90, is identified here as an essential factor for the activity of NS2/3 protease of hepatitis C virus. The cleavage activity of NS2/3 protease synthesized in reticulocyte lysate is ATP-dependent, as evidenced by ATP depletion experiments and inhibition with nonhydrolyzable...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 2001-11, Vol.98 (24), p.13931-13935
Main Authors: Waxman, Lloyd, Whitney, Michael, Pollok, Brian A., Kuo, Lawrence C., Darke, Paul L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c586t-1fdc50d674142ce0a159160066071a63a7b2817023accc807cad87494e2d9b163
cites cdi_FETCH-LOGICAL-c586t-1fdc50d674142ce0a159160066071a63a7b2817023accc807cad87494e2d9b163
container_end_page 13935
container_issue 24
container_start_page 13931
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 98
creator Waxman, Lloyd
Whitney, Michael
Pollok, Brian A.
Kuo, Lawrence C.
Darke, Paul L.
description The cellular chaperone, HSP90, is identified here as an essential factor for the activity of NS2/3 protease of hepatitis C virus. The cleavage activity of NS2/3 protease synthesized in reticulocyte lysate is ATP-dependent, as evidenced by ATP depletion experiments and inhibition with nonhydrolyzable ATP analogs. Geldanamycin and radicicol, ATP-competitive inhibitors of the chaperone HSP90, also inhibit the cleavage of in vitro-synthesized NS2/3. Furthermore, these HSP90 inhibitors prevent NS2/3 cleavage when the protease is expressed in mammalian cells. The physical association of NS2/3 with HSP90 is demonstrated by immunoprecipitation. Thus, by way of a chaperone/folding activity, an HSP90-containing complex is required for maturation of the polyprotein that encodes the enzymes essential for hepatitis C virus replication.
doi_str_mv 10.1073/pnas.241510898
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72298459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3057197</jstor_id><sourcerecordid>3057197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c586t-1fdc50d674142ce0a159160066071a63a7b2817023accc807cad87494e2d9b163</originalsourceid><addsrcrecordid>eNqFkUuLFDEUhYMoTju6dSVazELcVHtvksoDZiPtjC2MCKJuQzqV0mrq0ZOkZMZfb4pu28dCVyGc71zOvYeQxwhLBMle7gYbl5RjhaC0ukMWCBpLwTXcJQsAKkvFKT8hD2LcAoCuFNwnJ4gSZKX5grxejzEVK991xaV1aQzFB389tcH3fkhFk_9rv7OpTW0sVsXnNkyxuBi-3_a-eGfTFLI0Dg_JvcZ20T86vKfk0-XFx9W6vHr_5u3q1VXpKiVSiU3tKqiF5Mip82Cx0igAhACJVjArN1TlZJRZ55wC6WytJNfc01pvULBTcr6fu5s2va9djhhsZ3ah7W24NaNtzZ_K0H41X8ZvRiBynu3PD_YwXk8-JtO30eXV7eDHKRpJqVa80v8FUSGVjM4Tz_4Ct-MUhnwDQwGZyAvO0HIPuTDGGHxzDIxg5hLNXKI5lpgNT39f8xd-aC0Dzw7AbPwpa5VnGGSaYSZe_JswzdR1yd-kjD7Zo9uY6z-yDCqJWrIfHxS4vA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201361594</pqid></control><display><type>article</type><title>Host Cell Factor Requirement for Hepatitis C Virus Enzyme Maturation</title><source>Open Access: PubMed Central</source><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Waxman, Lloyd ; Whitney, Michael ; Pollok, Brian A. ; Kuo, Lawrence C. ; Darke, Paul L.</creator><creatorcontrib>Waxman, Lloyd ; Whitney, Michael ; Pollok, Brian A. ; Kuo, Lawrence C. ; Darke, Paul L.</creatorcontrib><description>The cellular chaperone, HSP90, is identified here as an essential factor for the activity of NS2/3 protease of hepatitis C virus. The cleavage activity of NS2/3 protease synthesized in reticulocyte lysate is ATP-dependent, as evidenced by ATP depletion experiments and inhibition with nonhydrolyzable ATP analogs. Geldanamycin and radicicol, ATP-competitive inhibitors of the chaperone HSP90, also inhibit the cleavage of in vitro-synthesized NS2/3. Furthermore, these HSP90 inhibitors prevent NS2/3 cleavage when the protease is expressed in mammalian cells. The physical association of NS2/3 with HSP90 is demonstrated by immunoprecipitation. Thus, by way of a chaperone/folding activity, an HSP90-containing complex is required for maturation of the polyprotein that encodes the enzymes essential for hepatitis C virus replication.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.241510898</identifier><identifier>PMID: 11707594</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Adenosine Triphosphate - metabolism ; Antibodies ; Benzoquinones ; Biological Sciences ; Cysteine Endopeptidases - genetics ; Cysteine Endopeptidases - metabolism ; Enzymes ; Gels ; Hepacivirus ; Hepacivirus - enzymology ; Hepatitis ; Hepatitis C ; Hepatitis C virus ; HSP90 Heat-Shock Proteins - antagonists &amp; inhibitors ; HSP90 Heat-Shock Proteins - metabolism ; Hsp90 protein ; Humans ; Inhibitory concentration 50 ; Jurkat Cells ; Lactams, Macrocyclic ; Lactones - pharmacology ; Low molecular weights ; Macrolides ; NS2/3 protein ; Plasmids ; Protein Processing, Post-Translational ; Proteins ; Quinones - metabolism ; Quinones - pharmacology ; RNA ; Ubiquitins ; Viruses</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2001-11, Vol.98 (24), p.13931-13935</ispartof><rights>Copyright 1993-2001 National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences Nov 20, 2001</rights><rights>Copyright © 2001, The National Academy of Sciences 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c586t-1fdc50d674142ce0a159160066071a63a7b2817023accc807cad87494e2d9b163</citedby><cites>FETCH-LOGICAL-c586t-1fdc50d674142ce0a159160066071a63a7b2817023accc807cad87494e2d9b163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/98/24.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3057197$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3057197$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11707594$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Waxman, Lloyd</creatorcontrib><creatorcontrib>Whitney, Michael</creatorcontrib><creatorcontrib>Pollok, Brian A.</creatorcontrib><creatorcontrib>Kuo, Lawrence C.</creatorcontrib><creatorcontrib>Darke, Paul L.</creatorcontrib><title>Host Cell Factor Requirement for Hepatitis C Virus Enzyme Maturation</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The cellular chaperone, HSP90, is identified here as an essential factor for the activity of NS2/3 protease of hepatitis C virus. The cleavage activity of NS2/3 protease synthesized in reticulocyte lysate is ATP-dependent, as evidenced by ATP depletion experiments and inhibition with nonhydrolyzable ATP analogs. Geldanamycin and radicicol, ATP-competitive inhibitors of the chaperone HSP90, also inhibit the cleavage of in vitro-synthesized NS2/3. Furthermore, these HSP90 inhibitors prevent NS2/3 cleavage when the protease is expressed in mammalian cells. The physical association of NS2/3 with HSP90 is demonstrated by immunoprecipitation. Thus, by way of a chaperone/folding activity, an HSP90-containing complex is required for maturation of the polyprotein that encodes the enzymes essential for hepatitis C virus replication.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Antibodies</subject><subject>Benzoquinones</subject><subject>Biological Sciences</subject><subject>Cysteine Endopeptidases - genetics</subject><subject>Cysteine Endopeptidases - metabolism</subject><subject>Enzymes</subject><subject>Gels</subject><subject>Hepacivirus</subject><subject>Hepacivirus - enzymology</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatitis C virus</subject><subject>HSP90 Heat-Shock Proteins - antagonists &amp; inhibitors</subject><subject>HSP90 Heat-Shock Proteins - metabolism</subject><subject>Hsp90 protein</subject><subject>Humans</subject><subject>Inhibitory concentration 50</subject><subject>Jurkat Cells</subject><subject>Lactams, Macrocyclic</subject><subject>Lactones - pharmacology</subject><subject>Low molecular weights</subject><subject>Macrolides</subject><subject>NS2/3 protein</subject><subject>Plasmids</subject><subject>Protein Processing, Post-Translational</subject><subject>Proteins</subject><subject>Quinones - metabolism</subject><subject>Quinones - pharmacology</subject><subject>RNA</subject><subject>Ubiquitins</subject><subject>Viruses</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkUuLFDEUhYMoTju6dSVazELcVHtvksoDZiPtjC2MCKJuQzqV0mrq0ZOkZMZfb4pu28dCVyGc71zOvYeQxwhLBMle7gYbl5RjhaC0ukMWCBpLwTXcJQsAKkvFKT8hD2LcAoCuFNwnJ4gSZKX5grxejzEVK991xaV1aQzFB389tcH3fkhFk_9rv7OpTW0sVsXnNkyxuBi-3_a-eGfTFLI0Dg_JvcZ20T86vKfk0-XFx9W6vHr_5u3q1VXpKiVSiU3tKqiF5Mip82Cx0igAhACJVjArN1TlZJRZ55wC6WytJNfc01pvULBTcr6fu5s2va9djhhsZ3ah7W24NaNtzZ_K0H41X8ZvRiBynu3PD_YwXk8-JtO30eXV7eDHKRpJqVa80v8FUSGVjM4Tz_4Ct-MUhnwDQwGZyAvO0HIPuTDGGHxzDIxg5hLNXKI5lpgNT39f8xd-aC0Dzw7AbPwpa5VnGGSaYSZe_JswzdR1yd-kjD7Zo9uY6z-yDCqJWrIfHxS4vA</recordid><startdate>20011120</startdate><enddate>20011120</enddate><creator>Waxman, Lloyd</creator><creator>Whitney, Michael</creator><creator>Pollok, Brian A.</creator><creator>Kuo, Lawrence C.</creator><creator>Darke, Paul L.</creator><general>National Academy of Sciences</general><general>National Acad Sciences</general><general>The National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20011120</creationdate><title>Host Cell Factor Requirement for Hepatitis C Virus Enzyme Maturation</title><author>Waxman, Lloyd ; Whitney, Michael ; Pollok, Brian A. ; Kuo, Lawrence C. ; Darke, Paul L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c586t-1fdc50d674142ce0a159160066071a63a7b2817023accc807cad87494e2d9b163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Antibodies</topic><topic>Benzoquinones</topic><topic>Biological Sciences</topic><topic>Cysteine Endopeptidases - genetics</topic><topic>Cysteine Endopeptidases - metabolism</topic><topic>Enzymes</topic><topic>Gels</topic><topic>Hepacivirus</topic><topic>Hepacivirus - enzymology</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatitis C virus</topic><topic>HSP90 Heat-Shock Proteins - antagonists &amp; inhibitors</topic><topic>HSP90 Heat-Shock Proteins - metabolism</topic><topic>Hsp90 protein</topic><topic>Humans</topic><topic>Inhibitory concentration 50</topic><topic>Jurkat Cells</topic><topic>Lactams, Macrocyclic</topic><topic>Lactones - pharmacology</topic><topic>Low molecular weights</topic><topic>Macrolides</topic><topic>NS2/3 protein</topic><topic>Plasmids</topic><topic>Protein Processing, Post-Translational</topic><topic>Proteins</topic><topic>Quinones - metabolism</topic><topic>Quinones - pharmacology</topic><topic>RNA</topic><topic>Ubiquitins</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Waxman, Lloyd</creatorcontrib><creatorcontrib>Whitney, Michael</creatorcontrib><creatorcontrib>Pollok, Brian A.</creatorcontrib><creatorcontrib>Kuo, Lawrence C.</creatorcontrib><creatorcontrib>Darke, Paul L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Waxman, Lloyd</au><au>Whitney, Michael</au><au>Pollok, Brian A.</au><au>Kuo, Lawrence C.</au><au>Darke, Paul L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Host Cell Factor Requirement for Hepatitis C Virus Enzyme Maturation</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2001-11-20</date><risdate>2001</risdate><volume>98</volume><issue>24</issue><spage>13931</spage><epage>13935</epage><pages>13931-13935</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>The cellular chaperone, HSP90, is identified here as an essential factor for the activity of NS2/3 protease of hepatitis C virus. The cleavage activity of NS2/3 protease synthesized in reticulocyte lysate is ATP-dependent, as evidenced by ATP depletion experiments and inhibition with nonhydrolyzable ATP analogs. Geldanamycin and radicicol, ATP-competitive inhibitors of the chaperone HSP90, also inhibit the cleavage of in vitro-synthesized NS2/3. Furthermore, these HSP90 inhibitors prevent NS2/3 cleavage when the protease is expressed in mammalian cells. The physical association of NS2/3 with HSP90 is demonstrated by immunoprecipitation. Thus, by way of a chaperone/folding activity, an HSP90-containing complex is required for maturation of the polyprotein that encodes the enzymes essential for hepatitis C virus replication.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>11707594</pmid><doi>10.1073/pnas.241510898</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2001-11, Vol.98 (24), p.13931-13935
issn 0027-8424
1091-6490
language eng
recordid cdi_proquest_miscellaneous_72298459
source Open Access: PubMed Central; JSTOR Archival Journals and Primary Sources Collection
subjects Adenosine Triphosphate - metabolism
Antibodies
Benzoquinones
Biological Sciences
Cysteine Endopeptidases - genetics
Cysteine Endopeptidases - metabolism
Enzymes
Gels
Hepacivirus
Hepacivirus - enzymology
Hepatitis
Hepatitis C
Hepatitis C virus
HSP90 Heat-Shock Proteins - antagonists & inhibitors
HSP90 Heat-Shock Proteins - metabolism
Hsp90 protein
Humans
Inhibitory concentration 50
Jurkat Cells
Lactams, Macrocyclic
Lactones - pharmacology
Low molecular weights
Macrolides
NS2/3 protein
Plasmids
Protein Processing, Post-Translational
Proteins
Quinones - metabolism
Quinones - pharmacology
RNA
Ubiquitins
Viruses
title Host Cell Factor Requirement for Hepatitis C Virus Enzyme Maturation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T15%3A27%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Host%20Cell%20Factor%20Requirement%20for%20Hepatitis%20C%20Virus%20Enzyme%20Maturation&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Waxman,%20Lloyd&rft.date=2001-11-20&rft.volume=98&rft.issue=24&rft.spage=13931&rft.epage=13935&rft.pages=13931-13935&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.241510898&rft_dat=%3Cjstor_proqu%3E3057197%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c586t-1fdc50d674142ce0a159160066071a63a7b2817023accc807cad87494e2d9b163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=201361594&rft_id=info:pmid/11707594&rft_jstor_id=3057197&rfr_iscdi=true